AU2020904491A0 - Compositions and uses thereof - Google Patents

Compositions and uses thereof

Info

Publication number
AU2020904491A0
AU2020904491A0 AU2020904491A AU2020904491A AU2020904491A0 AU 2020904491 A0 AU2020904491 A0 AU 2020904491A0 AU 2020904491 A AU2020904491 A AU 2020904491A AU 2020904491 A AU2020904491 A AU 2020904491A AU 2020904491 A0 AU2020904491 A0 AU 2020904491A0
Authority
AU
Australia
Prior art keywords
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020904491A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cymra Life Sciences Ltd
Original Assignee
Cymra Life Sciences Ltd
Filing date
Publication date
Application filed by Cymra Life Sciences Ltd filed Critical Cymra Life Sciences Ltd
Publication of AU2020904491A0 publication Critical patent/AU2020904491A0/en
Priority to US18/265,239 priority Critical patent/US20240131038A1/en
Priority to AU2021390590A priority patent/AU2021390590B2/en
Priority to EP21899353.3A priority patent/EP4255404A1/en
Priority to PCT/AU2021/051454 priority patent/WO2022115921A1/en
Priority to CA3200651A priority patent/CA3200651A1/en
Assigned to Cymra Life Sciences Limited reassignment Cymra Life Sciences Limited Amend patent request/document other than specification (104) Assignors: Cymra Life Sciences
Abandoned legal-status Critical Current

Links

AU2020904491A 2020-12-04 2020-12-04 Compositions and uses thereof Abandoned AU2020904491A0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US18/265,239 US20240131038A1 (en) 2020-12-04 2021-12-06 Anti-inflammatory compositions comprising cannabidiol, delta-9-tetrahydrocannabinol and linalool
AU2021390590A AU2021390590B2 (en) 2020-12-04 2021-12-06 Antiinflammatory compositions comprising cannabidiol, delta-9- tetrahydrocannabinol and linalool
EP21899353.3A EP4255404A1 (en) 2020-12-04 2021-12-06 Antiinflammatory compositions comprising cannabidiol, delta-9- tetrahydrocannabinol and linalool
PCT/AU2021/051454 WO2022115921A1 (en) 2020-12-04 2021-12-06 Antiinflammatory compositions comprising cannabidiol, delta-9- tetrahydrocannabinol and linalool
CA3200651A CA3200651A1 (en) 2020-12-04 2021-12-06 Antiinflammatory compositions comprising cannabidiol, delta-9- tetrahydrocannabinol and linalool

Publications (1)

Publication Number Publication Date
AU2020904491A0 true AU2020904491A0 (en) 2020-12-24

Family

ID=

Similar Documents

Publication Publication Date Title
EP3946358A4 (en) Allopregnanolone compositions and uses thereof
AU2022342169A1 (en) Hbb-modulating compositions and methods
AU2022344251A1 (en) Serpina-modulating compositions and methods
EP4181941A4 (en) Compositions and uses thereof
FI4103161T3 (en) Compositions and uses thereof
AU2021902682A0 (en) Compositions and uses thereof
AU2021902267A0 (en) Compositions and uses thereof
AU2021901822A0 (en) Compositions and uses thereof
AU2020904491A0 (en) Compositions and uses thereof
AU2023903761A0 (en) Compositions and uses thereof
AU2023902369A0 (en) Compositions and uses thereof
AU2022901597A0 (en) Compositions and uses thereof
AU2022901030A0 (en) Compositions and uses thereof
AU2022900574A0 (en) Compositions and uses thereof
AU2021902138A0 (en) Composition and uses thereof
AU2020903150A0 (en) Composition and uses thereof
AU2022401258A1 (en) Compositions and methods
AU2022342168A1 (en) Pah-modulating compositions and methods
AU2021900201A0 (en) Compositions and methods
AU2020904390A0 (en) Compositions and methods
AU2020902486A0 (en) Methods and compositions
AU2020901237A0 (en) Methods and compositions
AU2020900083A0 (en) Compositions and methods
AU2020900084A0 (en) Compositions and methods
AU2019904920A0 (en) Compositions and uses thereof